Title |
Intravenous ferric carboxymaltose for anaemia in pregnancy
|
---|---|
Published in |
BMC Pregnancy and Childbirth, March 2014
|
DOI | 10.1186/1471-2393-14-115 |
Pubmed ID | |
Authors |
Bernd Froessler, Joshua Collingwood, Nicolette A Hodyl, Gustaaf Dekker |
Abstract |
Iron deficiency is a common nutritional deficiency amongst women of childbearing age. Peri-partum iron deficiency anaemia (IDA) is associated with significant maternal, fetal and infant morbidity. Current options for treatment are limited: these include oral iron supplementation, which can be ineffective and poorly tolerated, and red blood cell transfusions, which carry an inherent risk and should be avoided. Ferric carboxymaltose is a new treatment option that may be better tolerated.The study was designed to assess the safety and efficacy of iron deficiency anaemia (IDA) correction with intravenous ferric carboxymaltose in pregnant women with mild, moderate and severe anaemia in the second and third trimester. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | <1% |
Unknown | 174 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 28 | 16% |
Researcher | 16 | 9% |
Other | 15 | 9% |
Student > Bachelor | 15 | 9% |
Student > Postgraduate | 11 | 6% |
Other | 37 | 21% |
Unknown | 53 | 30% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 73 | 42% |
Nursing and Health Professions | 16 | 9% |
Psychology | 9 | 5% |
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 3% |
Social Sciences | 3 | 2% |
Other | 14 | 8% |
Unknown | 55 | 31% |